Ebrahiminik Hojat, Nikpour Shahriar, Yazdi Hadi Rokni, Mohammadi Afshin, Mirza-Aghazadeh-Attari Mohammad
Department of Interventional Radiology and Radiation Sciences Research Centre, AJA University of Medical Sciences, Tehran Iran.
Department of Adult Gastroenterology and Hepatology, School of Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Radiol Case Rep. 2021 Jun;16(6):1539-1542. doi: 10.1016/j.radcr.2021.03.038. Epub 2021 Mar 24.
Coronavirus disease (COVID-19) is associated with thrombosis formation in various vessels, including those in the abdomen. In this case report, we present a COVID-19 infected patient who had developed abdominal discomfort. The patient underwent magnetic resonance imaging, which showed signs of thrombosis formation in the superior mesenteric vein (SMV). After conservative treatment failed, the patient was considered for vascular intervention. The SMV clot underwent thrombolysis via the infusion of reteplase (dose 6 mg stat, followed by 1 mg every hour) through a 5F perfusion Cather (Cragg-McNamara, 20 cm). Control venography showed near-complete recanalization. The patient was discharged with oral anticoagulants. Our case report is one of the first incidents of successful vascular intervention in SMV thrombosis in the setting of COVID-19.
冠状病毒病（COVID-19）与包括腹部血管在内的各种血管内血栓形成有关。在本病例报告中，我们介绍了一名出现腹部不适的COVID-19感染患者。该患者接受了磁共振成像检查，结果显示肠系膜上静脉（SMV）有血栓形成迹象。保守治疗失败后，考虑对该患者进行血管介入治疗。通过一根5F灌注导管（Cragg-McNamara，20 cm）注入瑞替普酶（剂量为静脉推注6 mg，随后每小时1 mg）对SMV血栓进行溶栓治疗。对照静脉造影显示几乎完全再通。患者出院时服用口服抗凝剂。我们的病例报告是COVID-19背景下成功对SMV血栓进行血管介入治疗的首批案例之一。
